For type 2 diabetes mellitus. ANDA 215008, held by Annora Pharma. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 215008 (Metformin Hydrochloride), held by Annora Pharma, was first approved by FDA on Mar 13, 2025, with 1 approved supplement and 0 published complete response letters.
Metformin hydrochloride oral solution is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 13, 2025 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metformin Hydrochloride500MG/5ML · solution;oral | Metformin Hydrochloride | Rx |
| Aug 27, 2026 | Supplement 2Labeling · Standard review | Approved | None posted |
| Mar 13, 2025 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters